Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: Studies with nicotinamide and hyperthermia

British Journal of Radiology

Volumn 70, Issue APR., 1997, Pages 391-398

  Masunaga, S ^a   Ono, K ^a   Suzuki, M ^a   Takagaki, M ^a   Sakurai, Y ^a   Kobayashi, T ^a   Akuta, K ^b   Akaboshi, M ^a   Kinashi, Y ^a   Abe, M ^c  

^a KYOTO UNIVERSITY   (Japan)

^b OTSU RED CROSS HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BORATE SODIUM; BORON; BORON DERIVATIVE; BROXURIDINE; CYTOCHALASIN B; NICOTINAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL KILLING; CELL POPULATION; CELL PROLIFERATION; CELL SUSPENSION; FEMALE; HYPERTHERMIC THERAPY; IMMUNOFLUORESCENCE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MICRONUCLEUS; MOUSE; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; ORAL DRUG ADMINISTRATION; TUMOR CELL;

EID: 0030995079     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.70.832.9166076     Document Type: Article

References (24)

1. Wazer DE, Zamenhof RG, Harling OK, MadocJones H. Boron neutron capture therapy. In: Mauch PM, Loeffler JS, editors. Radiation Oncology: Technology and Biology. Philadelphia: WB Saunders, 1994:167-97.
2. Barth RF, Soloway AH, Fairchild RG, Brugger RM. Boron neutron capture therapy for cancer. Cancer 1992;70:2995-3007.
3. Dethlefsen LA. In quest of the quaint quiescent cells. In: Meyn RE, Withers HR, editors. Radiation Biology in Cancer Research. New York: Raven Press, 1980:415-35.
4. Masunaga S, Ono K, Abe M. A method for selective measurement of the radiosensitivity of quiescent cells in solid tumors - combination of immunofluorescence staining to BrdU and micronucleus assay. Radiat Res 1991;25:243-7.
5. Horsman MR, Wood PJ, Chaplin DJ, et al. The potentiation of radiation damage by nicotinamide in the SCC VII tumour in vivo. Radiother Oncol 1990;18:49-57.
6. 195mPt-radiolabelled cis-diaminedichloroplatinum(II). Int J Radiat Biol 1994;66:215-20.
7. Kanda K. An overview: radiation sources, beam quality, dosimetry and spectroscopy in neutron capture therapy. Strahlenther Onkol 1989;165:67-9.
8. 10B concentrations and absorbed dose estimations in human malignant melanoma treated by BNCT. Strahlenther Onkol 1989;165:104-6.
9. Mitchell J, Morstyn G, Russo A, et al. Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. Int J Radiat Oncol Biol Phys 1984;10:1447-51.
10. Midander J, Revesz L. The frequency of micronucleus as a measure of cell survival in irradiated cell populations. Int J Radiat Biol 1980;38:237-242.
11. Peters LJ, Brock WA, Johnson T, et al. Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys 1986;12:459-67.
12. Roberts CJ, Morgan GA, Holt PD. A critical comparison of the micronucleus yield from high and low LET irradiation of plateau-phase cell populations. Mutat Res 1986;160:237-42.
13. Brock WA, Williams M. Kinetics of micronucleus expression in synchronized irradiated Chinese hamster ovary cells. Cell Tissue Kinet 1985;18:247-54.
14. Fenech M, Morley A. Solutions to the kinetic problem in the micronucleus assay. Cytobios 1985;43:233-46.
15. Ono K, Wandl EO, Tsutsui M, et al. The correlation between cell survival curve and dose response curve of micronucleus (MN) frequency. Strahlenther Onkol 1989;165:824-7.
16. Ono K, Masunaga S, Kinashi Y, et al. Radiobiological evidence suggesting heterogenous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996;34:1081-6.
17. Masunaga S, Ono K, Akuta K, et al. The response of quiescent cell populations in murine solid tumors to irradiation with fast neutrons. Acta Oncol 1994;33:813-17.
18. Masunaga S, Ono K, Abe M. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours. Br J Radiol 1993;66:918-26.
19. Horsman MR, Nordsmark M, Khalil AA, et al. Reducing acute and chronic hypoxia in tumors by combining nicotinamide with carbogen breathing. Acta Oncol 1994;33:371-6.
20. Jackson RC. The problem of the quiescent cancer cell. Adv Enzyme Regulation 1989;29:27-46.
21. Hainfeld JF. Uranium-loaded apoferritin with antibodies attached: molecular design for uranium neutron-capture therapy. Proc Natl Acad Sci USA 1992;89:11064-8.
22. Akine Y, Tokita N, Tukuuye K, et al. Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice. Jpn J Clin Oncol 1993;23:145-8.
23. Shih JL, Brugger RM. Gadolinium as a neutron capture therapy agent. Med Phys 1992;19:733-44.
24. Lajtha LG. On the concepts of the cell cycle. Cell Comp Physiol 1963;62:143-5.